NEJM:雅库关节炎(Jaccoud''s Arthropathy)病例报道

2015-07-19 MedSci MedSci原创

一名58岁的男性患者,以往有15年的系统性红斑狼疮病史,今次来院就诊的主要症状表现为多发性关节炎、对光敏感、颧部红斑和胸膜炎。实验室检查发现抗核抗体,抗–双链DNA抗体,抗Ro(SS-A)抗体,非–肾病范围的蛋白尿,以及白细胞减少症。类风湿因子和抗CCP抗体检测结果均为阴性。尽管在10年前开始使用糖皮质激素、羟氯喹和硫唑嘌呤进行治疗,但最终还是出现了手部畸形,包括天鹅颈畸形,Z畸形拇指,小指尺偏差

一名58岁的男性患者,以往有15年的系统性红斑狼疮病史,今次来院就诊的主要症状表现为多发性关节炎、对光敏感、颧部红斑和胸膜炎。


实验室检查发现抗核抗体,抗–双链DNA抗体,抗Ro(SS-A)抗体,非–肾病范围的蛋白尿,以及白细胞减少症。类风湿因子和抗CCP抗体检测结果均为阴性。

尽管在10年前开始使用糖皮质激素、羟氯喹和硫唑嘌呤进行治疗,但最终还是出现了手部畸形,包括天鹅颈畸形,Z畸形拇指,小指尺偏差(请参照图A和视频)。所有的这些症状都符合雅库关节炎的表现。作磁共振检查,结果显示无骨侵蚀的现象。

以往,雅库关节炎在风湿热疾病中曾有过经典的描述,现今在SLE和其他弥漫性结缔组织疾病中也被提及和有相关地描述。

雅库关节病,主要导致畸形结果的病理生理是由于软组织异常,如韧带松弛,纤维化胶囊,与肌肉的不平衡,而不是骨关节的破坏,如类风湿性关节炎。对于雅库关节病的治疗方法,目前主要是包括物理治疗和矫正装置的使用。

由于该男患者职业是一名出租车司机,尽管肌肉加强物理治疗对他的疾病有很大的帮助,但手部的畸形却影响到他以后是否能继续从事这份职业。

目前,针对该男患者手部畸形的软组织矫正手术正在策划中。

原文出处:
Santiago M, Machicado V. IMAGES IN CLINICAL MEDICINE. Jaccoud's Arthropathy. N Engl J Med. 2015 Jul 2;373(1):e1.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1853373, encodeId=c6e518533e30c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 25 01:23:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933575, encodeId=6cb619335e527, content=<a href='/topic/show?id=04cb1354312' target=_blank style='color:#2F92EE;'>#OUD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13543, encryptionId=04cb1354312, topicName=OUD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Sat Feb 13 14:23:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265254, encodeId=31701265254c1, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325064, encodeId=4d741325064e9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355994, encodeId=cfed13559945e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=)]
    2016-01-25 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1853373, encodeId=c6e518533e30c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 25 01:23:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933575, encodeId=6cb619335e527, content=<a href='/topic/show?id=04cb1354312' target=_blank style='color:#2F92EE;'>#OUD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13543, encryptionId=04cb1354312, topicName=OUD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Sat Feb 13 14:23:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265254, encodeId=31701265254c1, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325064, encodeId=4d741325064e9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355994, encodeId=cfed13559945e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=)]
    2016-02-13 zxxiang
  3. [GetPortalCommentsPageByObjectIdResponse(id=1853373, encodeId=c6e518533e30c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 25 01:23:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933575, encodeId=6cb619335e527, content=<a href='/topic/show?id=04cb1354312' target=_blank style='color:#2F92EE;'>#OUD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13543, encryptionId=04cb1354312, topicName=OUD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Sat Feb 13 14:23:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265254, encodeId=31701265254c1, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325064, encodeId=4d741325064e9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355994, encodeId=cfed13559945e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=)]
    2015-07-21 lmm397
  4. [GetPortalCommentsPageByObjectIdResponse(id=1853373, encodeId=c6e518533e30c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 25 01:23:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933575, encodeId=6cb619335e527, content=<a href='/topic/show?id=04cb1354312' target=_blank style='color:#2F92EE;'>#OUD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13543, encryptionId=04cb1354312, topicName=OUD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Sat Feb 13 14:23:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265254, encodeId=31701265254c1, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325064, encodeId=4d741325064e9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355994, encodeId=cfed13559945e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1853373, encodeId=c6e518533e30c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Jan 25 01:23:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933575, encodeId=6cb619335e527, content=<a href='/topic/show?id=04cb1354312' target=_blank style='color:#2F92EE;'>#OUD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13543, encryptionId=04cb1354312, topicName=OUD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Sat Feb 13 14:23:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265254, encodeId=31701265254c1, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325064, encodeId=4d741325064e9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355994, encodeId=cfed13559945e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jul 21 08:23:00 CST 2015, time=2015-07-21, status=1, ipAttribution=)]
    2015-07-21 zhaojie88

相关资讯

Neurology:关节炎药物增加中风死亡风险

项刊登在国际杂志Neurology上的研究报告中,来自奥胡斯大学的研究人员发现,一种用于治疗关节炎和疼痛的常用药物或许可以增加个体因中风而死亡的风险;据美国CDC数据显示,在美国中风是第四大致人死亡的主要疾病。 文章中研究者检测的药物都是环氧化酶-2(COX-2)抑制剂,包括老药双氯芬酸、依托度酸、萘丁美酮和美洛昔康,同时研究人员利用昔布类的新药也进行了检测,包括塞来考昔和罗非昔布;COX-

ACR:女性喝牛奶可减缓退化性关节炎恶化

最近,一项最新的研究显示,常饮脱脂和低脂牛奶,女性可减缓退化性关节炎恶化。但是如果女性吃奶酪,反而可能会加速退化性关节炎病程,至于酸奶则对退化性关节炎病程影响不大,无论对男性、女性患者都一样。 发表在最近出版的《关节炎护理与研究》期刊上的这项研究称,退化性关节炎常造成关节疼痛、肿胀,像膝关节、髋关节、手部关节都可能出现退化性关节炎。 在美国25岁以上的人群中,约有近2700万人患有退化性关节炎

Arthritis Res Ther:艾灸或可缓解关节炎膝关节痛

艾灸是传统中医的一种治疗手段。6月24日在线发表于《关节炎研究和治疗(Arthritis Research and Therapy)》的一项新研究指出,在膝骨关节炎患者中进行约18周的艾灸,或可安全缓解其疼痛并改善其功能。这项随机、双盲研究使用了安慰剂对照,纳入的110例患者符合美国风湿病学会的膝骨关节炎诊断标准,且在此前一个月内疼痛评分≥3/10分(10分制视觉模拟评分)。既往6个月内接受过艾灸

PLoS Pathog:口腔牙龈卟啉单胞菌可能加速关节炎病程

认真刷牙可以保护口腔健康,而且医学界研究发现,刷牙刷得好,对心脏健康也有关联益处。最近美国的一项研究又发现,认真刷牙可以帮助对抗关节炎。 美国路易斯维尔大学的研究人员在新一期在线期刊《科学公共图书馆—病原体》上介绍说,诱发牙周疾病的一种主要细菌“牙龈卟啉单胞菌”,会产生一种特定的酶。在这种酶的催化下,某些特定蛋白质的“残基”(蛋白质上的特定单元)会转变为瓜氨酸。这时机体就会把这样的蛋白质误认作“入

首战告捷:礼来关节炎药物baricitinib关键III期大获成功

礼来和合作伙伴Incyte近日公布了类风湿性关节炎(RA)药物baricitinib关键III期RA-BEACON研究的积极顶线数据。 该研究在527例既往经至少一种抗肿瘤坏死因子(TNF)制剂(包括重磅药物阿达木单抗Humira和依那西普Enbrel)治疗失败正服用稳定剂量常规疾病修饰抗风湿药物(cDMARD)的中度至重度类风湿性关节炎(RA)患者中开展。 研究中,除了接受cDMARDs背景

JAMA Dermatol:托法替尼(Tofacitinib)——白癜风治疗的新希望

托法替尼——白癜风治疗的新希望据近日发表在JAMA Dermatology上的一项研究表明,通常用于治疗关节炎症的药物或可用于白癜风的治疗。该研究对象为一名53岁的女性患者,其面部,手以及躯干部位存在明显白色斑块。虽然患者已经接受了药物和光疗法,但是这些治疗并没有阻止病情的进展。托法替尼已成功的治疗了斑秃,因此, Dr. King 以及该研究的共同作者 Dr. Brittany Craiglow